Presentations by Cécilia Thomine

• Sat-28 from 13:30 - 15:00 in room Confederation III
  Poster Session — Poster Session II
  Interest of HDAC inibitor belinostat, in monotherapy or in association with Bcl-xL or Mcl-1 inhibitors, in ovarian cancer treatment